The delegation of Yan Aoshuang, Director of Beijing Municipal Science & Technology Commission, Ren Guoquan, Director of Medical Department in the General Hospital of Chinese People's Liberation Army(301 Hospital), and Guo Yajun, Director of Cancer Center reviewed YRPG on February 5, with the accompany of President Xu Jingren, Xu Haoyu, and Sun Tianjiang.
The delegation of Yan Aoshuang inspected the high-rack warehouse, freeze-dried powder workshop, and quality inspection center to understand the current development situation of YRPG in detail. During their inspection, the beautiful environment, advanced production testing devices, and strict norms of quality inspection process in YRPG were acclaimed by the leaders in succession. Yan Aoshuang said with great happiness that she was also a faithful customer of YRPG’s product. As her throat used to be uncomfortable, she felt much better after taking Lanqin Oral Liquid.
In the following conversazione, Yan Aoshuang stated that YRPG was a banner of Chinese national medicine and Beijing Municipal Science & Technology Commission would fully support YRPG’s international development strategy by making more efforts to serve YRPG and establishing the easy access; besides they would specially support YRPG’s key innovation projects and strive for YRPG’s foreign cooperation matchmaking.
With the active assistance of Beijing Municipal Science & Technology Commission, Beijing Municipal Science & Technology Commission, 301 Hospital, and YRPG signed the “Strategic Cooperation Agreement on Beijing Antibody Drug Development Platform Establishment” in January this year. The R&D platform has actively promoted the industrialization of technology achievements, which was a beneficial attempt to implement technology innovation and scientific system innovation under the new situation.